Literature DB >> 12818417

Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency.

Livia Pisciotta1, Roberto Miccoli, Alfredo Cantafora, Laura Calabresi, Patrizia Tarugi, Paola Alessandrini, Gabriele Bittolo Bon, Guido Franceschini, Claudio Cortese, Sebastiano Calandra, Stefano Bertolini.   

Abstract

Two siblings with high density lipoprotein (HDL) deficiency and no plasma apolipoprotein A-I (Apo A-I) were found to be homozygous for a cytosine deletion in exon 3 of Apo A-I gene (c.85 del C, Q5FsX11). This mutation causes a frameshift leading to a premature stop codon and abolishes the synthesis of Apo A-I. Although both siblings had corneal opacifications and planar xanthomas, only one of them had premature coronary artery disease, probably as the result of mildly elevated LDL levels. In two other unrelated subjects HDL deficiency was due to heterozygosity for a nucleotide substitution in exon 4 of Apo A-I gene (c.494 T>G, L141R). Both Apo A-I mutations were reported previously in an Italian kindred which included compound heterozygotes and simple heterozygotes. We investigated all carriers of these mutations in the three kindreds and in the one previously reported. Plasma Apo A-I and HDL-C levels were lower in the mutation carriers than in non-carrier family members. These levels, however, were lower in L141R carriers than in carriers of c.85 del C. Haplotype analysis performed using several polymorphisms suggested that both the c.85 del C and L141R are likely to be recurrent mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818417     DOI: 10.1016/s0021-9150(03)00020-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 2.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

3.  Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.

Authors:  Raul D Santos; Bela F Asztalos; Lilton R C Martinez; Marcio H Miname; Eliana Polisecki; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2008-06-13       Impact factor: 4.766

Review 4.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

5.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

6.  Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice.

Authors:  Michelle Bamji-Mirza; Wandong Zhang; Zemin Yao
Journal:  J Biomed Res       Date:  2014-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.